GE HealthCare Technologies Inc. (LON:0ADL)
London · Delayed Price · Currency is GBP · Price in USD 70.60
-1.03 (-1.44%)
At close: Nov 18, 2025
LON:0ADL Revenue
GE HealthCare Technologies had revenue of $5.14B USD in the quarter ending September 30, 2025, with 5.76% growth. This brings the company's revenue in the last twelve months to $20.25B, up 3.51% year-over-year. In the year 2024, GE HealthCare Technologies had annual revenue of $19.67B with 0.61% growth.
Revenue (ttm)
$20.25B
Revenue Growth
+3.51%
P/S Ratio
1.73
Revenue / Employee
$382.00K
Employees
53,000
Market Cap
26.01B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.67B | 120.00M | 0.61% |
| Dec 31, 2023 | 19.55B | 1.21B | 6.60% |
| Dec 31, 2022 | 18.34B | 756.00M | 4.30% |
| Dec 31, 2021 | 17.59B | 421.00M | 2.45% |
| Dec 31, 2020 | 17.16B | 531.00M | 3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |